Non-mydriatic retinal camera FC161: High-resolution imaging for screening and monitoring of eye conditions
The non-mydriatic retinal camera FC161 sets a new standard in retinal imaging with its cutting-edge Auto Split Focusing technology, which enables lightning-fast focusing speed reaching milliseconds. This innovative feature effectively mitigates the risk of capturing out-of-focus fundus images caused by patient movement during the imaging process. By minimizing such disruptions, FC161 significantly enhances image quality while reducing the demands for patient cooperation, streamlining the examination experience for both operators and patients.
Equipped with state-of-the-art technology, FC161 delivers high-resolution fundus images with remarkable clarity, boasting an impressive image resolution of up to 12 Mega Pixels. This exceptional level of detail empowers clinicians with the ability to identify early lesions with unparalleled accuracy, facilitating timely interventions and precise treatment planning. Such precision is indispensable in the diagnosis and management of various retinal diseases, including but not limited to diabetic retinopathy, glaucoma, and macular degeneration.
Beyond its technical prowess, FC161 offers a comprehensive solution for retinal imaging that prioritizes patient comfort and convenience. Its user-friendly design and intuitive operation ensure a smooth and efficient imaging process, minimizing discomfort and maximizing compliance among patients. With FC161, clinicians can perform thorough examinations of the retina quickly and comfortably, enabling swift screenings, accurate diagnoses, and effective monitoring of ocular health.
The non-mydriatic retinal camera FC161 offers remarkable versatility and efficiency, revolutionizing the retinal imaging process with its advanced features and user-friendly design. With a minimum pupil diameter requirement of φ3.0mm, FC161 eliminates the need for mydriatic agents, saving patients from the inconvenience of a 20-minute waiting period and reducing the risk associated with mydriasis. This not only enhances patient comfort but also expedites the imaging process, allowing clinicians to proceed with examinations swiftly and efficiently.
Equipped with 9 fixation targets, FC161 covers an impressive 85° field of view of the fundus, facilitating the detection of early peripheral lesions with unparalleled precision. Additionally, its 45° field of view enables the capture of single central fundus images, meeting the demands of fundus disease screening with utmost effectiveness. The inclusion of a 4.3" full-touch LED screen enhances the operational experience, providing doctors with intuitive control over image zooming and editing. This feature allows clinicians to scrutinize fundus details with ease and make informed decisions regarding patient care.
Moreover, FC161 offers seamless integration with Mediview Patient Management software, enabling real-time synchronization between fundus images and patient records via WIFI connection. This innovative functionality enhances workflow efficiency and ensures accurate documentation, empowering clinicians with comprehensive insights into patient health and facilitating informed decision-making.
In summary, the non-mydriatic retinal camera FC161 represents a breakthrough in retinal imaging technology, combining exceptional imaging capabilities with user-centric features to deliver unparalleled performance and clinical utility. From its ability to capture high-resolution fundus images to its seamless connectivity with patient management software, FC161 sets a new standard for efficiency, accuracy, and convenience in retinal examinations.
